Interviews with the world’s key opinion leaders in cancer

Tagmetastatic castration-resistant prostate cancer

AJO Oncology Video

Initial Gleason score does not predict abiraterone response in patients with metastatic castration-resistant prostate cancer

February 12, 2014

SAN FRANCISCO— Gleason score at initial diagnosis was not predictive of response to abiraterone in patients with metastatic castration-resistant...